2000
DOI: 10.1042/cs0980703
|View full text |Cite
|
Sign up to set email alerts
|

Myocardial infarction with and without reperfusion in sheep: early cardiac and neurohumoral changes

Abstract: There are few stable and reproducible large-animal models of chronic heart failure produced by ischaemic damage to the myocardium. Here we characterize a novel method of inducing myocardial damage in closed-chest sheep by catheter delivery of thrombogenic coils, and compare this with a newly described open-artery model of cardiac injury in sheep. Sham controls were compared with animals subjected to (a) 90 min of coronary artery occlusion/reperfusion by PTCA (percutaneous transluminal coronary angioplasty) bal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
13
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 24 publications
1
13
0
Order By: Relevance
“…Angioblast Systems, Inc., acquired the technology and developed the allogeneic MSC product Revascor ™ for clinical use primarily in the treatment of ischaemic cardiovascular disease. [9295] To date, more than 20 congestive heart failure patients have received injections of Revascor ™ with no adverse events related to the cells (Dr. Silviu Itescu, Angioblast Systems, Inc., personal communication ). Angioblast has agreed to supply Revascor ™ as an ‘off-the-shelf’ product for the M. D. Anderson CB MNC/MSC co-culture expansion trial.…”
Section: J Rationale For the Use Of “Off-the-shelf” Msc For The Clinmentioning
confidence: 99%
“…Angioblast Systems, Inc., acquired the technology and developed the allogeneic MSC product Revascor ™ for clinical use primarily in the treatment of ischaemic cardiovascular disease. [9295] To date, more than 20 congestive heart failure patients have received injections of Revascor ™ with no adverse events related to the cells (Dr. Silviu Itescu, Angioblast Systems, Inc., personal communication ). Angioblast has agreed to supply Revascor ™ as an ‘off-the-shelf’ product for the M. D. Anderson CB MNC/MSC co-culture expansion trial.…”
Section: J Rationale For the Use Of “Off-the-shelf” Msc For The Clinmentioning
confidence: 99%
“…Troponin is a globular protein complex localised on thin filaments of striated muscle and consists of three subunits; Tn-T, Tn-I and Tn-C; all three subunits are integrally involved in the contraction and relaxation of the myofibrils (Klaus 1990, Billeter and others 1994, Cardinet 1997, Reece 1997, Rice 1999, Boccara and others 2000). Troponin complex proteins have been determined in the heart muscle and blood of domestic animals (McAuliffe and Robbins 1991, O'Brien and others 1997b, 1998, Charles and others 2000, Fredericks and others 2001, Gonzales and others 2005, Gunes and others 2005, Jesty and others 2005). There is remarkable homology between the amino acid sequences of cTn in human beings and animals (O'Brien and others 1997a, 1998), but there have been few studies of its potential clinical use in veterinary medicine.…”
mentioning
confidence: 99%
“…Venous blood drawn for hormone assay was taken into chilled EDTA-coated tubes, centrifuged and the plasma stored at k80 mC before assay for plasma atrial natriuretic peptide (ANP) [9], brain natriuretic peptide (BNP) [10], N-terminal fragment of pro-BNP (NT-BNP) [11], cGMP [9], endothelin [1], aldosterone [12] and plasma renin activity (PRA) [13].…”
Section: Neurohumoral Measurementsmentioning
confidence: 99%
“…Regional wall motion (fractional shortening) was calculated in four quadrants (1)(2)(3)(4), these being posterobasal, diaphragmatic, apical anterolateral and anterobasal respectively. A 7F pigtail catheter was passed through the carotid artery sheath into the left ventricle and a 20 ml bolus of contrast medium (Omnipaque, Nycomed, Birmingham, U.K.) was injected under fluoroscopy with the image captured on video for analysis on an ANCOR workstation (Siemens, Solna, Sweden).…”
Section: Neurohumoral Measurementsmentioning
confidence: 99%
See 1 more Smart Citation